Clinical patient recruitment plays an important role in clinical research, resulting in many new and improved therapies for patients. Covid-19 pandemic impacted the economies of most countries; therefore the fast drug development is the utmost important for the disease.

Global Clinical Trials began the latest COVID-19 therapy trial in January 2022 and completed patient recruitment in just 3 weeks instead of the projected 4 months. In total 95 patients were enrolled into a Phase II clinical study of the anti-inflammatory medication for the treatment of hospitalized patients.

Contact us at bd@gctrials.com  to get a quick feasibility analysis for infectious diseases studies including COVID-19.